finance

Wegovy: Weight-loss drug firm becomes Europe's most valuable



Shares rose after the Danish pharmaceutical giant Novo Nordisk launched Wegovy in the UK.



READ SOURCE

Readers Also Like:  Rosenblatt maintains NVIDIA at 'buy' with a price target of $800.00

This website uses cookies. By continuing to use this site, you accept our use of cookies.